医科学専攻 障害科学専攻
- Master's Courses
修士課程 - Doctoral Courses
博士課程
Epileptologyてんかん学
STAFF
Professor
-
Tomita, HiroakiProfessor. 富田 博秋 教授 (兼任)
Other Faculty / Staff
-
Jin, Kazutaka
Assoc.Prof. 神 一敬 准教授 -
Kakisaka, Yosuke
Assoc.Prof. 柿坂 庸介 准教授(兼) -
Ukishiro, Kazushi
Lect. 浮城 一司 講師 -
Fujikawa, Mayu
Assistant Prof. 藤川 真由 助教 -
Ogawa, Maimi
Assistant Prof. 小川 舞美 助教 -
Ishida, Makoto
Assistant Prof. 石田 誠 助教(兼)
CONTACT
TEL:+81-22-717-7343
E-MAIL:hello_epi*epilepsy.med.tohoku.ac.jp
(「*」を「@」に変換してください)
OUTLINE
Department of Epileptology began operations in February 2010. Epilepsy is a disorder characterized by recurrent episodes of paroxysmal brain dysfunction caused by sudden, disorderly, and excessive neuronal discharges. Epilepsy is also associated with various interictal neurological, mental, and physical symptoms. The prevalence of epilepsy is about 1% worldwide. Patients and the public generally misunderstand that epilepsy is an untreatable disease. In addition, general physicians and even specialists in other neurological diseases often fail to consult specialists in epilepsy to establish the correct diagnosis before starting treatment. Department of Epileptology is intended to establish a comprehensive epilepsy program, including group medical services provided by neurologists, neurophysiologists, radiologists, pediatricians, psychiatrists, neurosurgeons, specialized nurses, psychologists, EEG-techs, pharmacists, and social workers; advance both basic and clinical research into epilepsy and related brain functions; develop human resources for these medical services; and provide education about epilepsy for patients, their families, the public, general physicians, and specialists in neurological diseases. Department of Epileptology provides international facilities for physicians, researchers, students, and social workers intending to study the many aspects of epilepsy to provide treatments to normalize the lives of patients with epilepsy.
てんかんの有病率は約1%で、赤ちゃんからお年寄りまで、いつでも誰でも「てんかん」と診断される可能性があります。みずから病名を公表する人は少なく、患者数は実際より少なく見積もられています。これまで日本では、てんかん学を掲げた研究分野はありませんでした。私たちは「てんかん学分野」を名乗り、疾患の診断と治療、そして誤解や偏見に正面から立ち向かいます。
初診外来では1名に1時間をかけて発作症状や悩みを確認します。必要な場合、2週間の入院精査を行います。長時間ビデオ脳波モニタリングでは、発作時の症状と脳波から、従来の診断が覆されることがしばしばです。公認心理師が患者や家族の心理社会的問題を評価します。てんかんでは薬物治療が最初の選択ですが、薬が無効なら外科治療も行います。頭蓋内に電極を留置して行う検査もあります。研究面では工学部と共同で全く新しい脳磁図センサの開発も行っています。
てんかん学分野では、疾患の周辺にある社会的問題にも取り組んでいます。てんかん学を通じ、さまざまな分野で活躍できる人材を育てることが研究室としてのゴールです。
Purple Day Miyagi 2024 (epilepsy awareness event)
てんかん啓発イベント 宮城パープルデー2024Hosting Annual Meeting of the Japan Epilepsy Society, Sendai, 2022
日本てんかん学会学術集会を主催(2022年)
ARTICLE
Ukishiro K, et al. Complete corpus callosotomy brings worthwhile seizure reduction in both pediatric and adult patients. Neurosurgery 96:410-415, 2025
URL:https://doi.org/10.1227/neu.0000000000003092
Ogawa M, et al. Individual and relational factors related to disclosure of epilepsy in the workplace. Epilepsy Behav 160:110079, 2024
URL:https://doi.org/10.1016/j.yebeh.2024.110079
Ishida M, et al. Somatosensory evoked spikes in normal adults detected by magnetoencephalography. Clin Neurophysiol 164:19-23, 2024
URL:https://doi.org/10.1016/j.clinph.2024.05.006
Konomatsu K, et al. Referral odyssey plot to visualize causes of surgical delay in mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsy Behav 147:109434, 2023
URL:https://doi.org/10.1016/j.yebeh.2023.109434
Jin K, et al. Prescription trends in anti-seizure medications for adult patients with epilepsy in Japan: A retrospective cohort study using the database of health insurance claims between 2015 and 2019. Epilepsy Behav 134:108841, 2022
URL:https://doi.org/10.1016/j.yebeh.2022.108841